C12Y 105/00
Oxidoreductases acting on the ch-nh group of donors
Official title: Oxidoreductases acting on the CH-NH group of donors (1.5)
C12Y105/00 (Oxidoreductases acting on the ch-nh group of donors) appears on 169 US grants and 299 published applications in this corpus.
Search patents in C12Y- Granted patents
- 169
- Published applications
- 299
- Assignees
- 164
- Inventors
- 722
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 2 |
| 2003 | 2 | 3 |
| 2004 | 1 | 2 |
| 2005 | 0 | 4 |
| 2006 | 2 | 3 |
| 2007 | 1 | 2 |
| 2008 | 2 | 2 |
| 2009 | 0 | 2 |
| 2010 | 1 | 3 |
| 2011 | 2 | 3 |
| 2012 | 0 | 4 |
| 2013 | 1 | 6 |
| 2014 | 2 | 9 |
| 2015 | 5 | 15 |
| 2016 | 6 | 15 |
| 2017 | 10 | 18 |
| 2018 | 19 | 18 |
| 2019 | 10 | 32 |
| 2020 | 10 | 24 |
| 2021 | 17 | 22 |
| 2022 | 17 | 21 |
| 2023 | 11 | 19 |
| 2024 | 10 | 24 |
| 2025 | 19 | 24 |
| 2026 | 13 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 105/01Oxidoreductases acting on the ch-nh group of donors: with nad+ or nadp+139
- C12Y 105/03Oxidoreductases acting on the ch-nh group of donors: with oxygen as acceptor25
- C12Y 105/99Oxidoreductases acting on the ch-nh group of donors: with other acceptors3
- C12Y 105/05Oxidoreductases acting on the ch-nh group of donors: with a quinone or1
- C12Y 105/04Oxidoreductases acting on the ch-nh group of donors: with a disulfide as0
- C12Y 105/07Oxidoreductases acting on the ch-nh group of donors: with an iron-sulfur protein0
- C12Y 105/08Oxidoreductases acting on the ch-nh group of donors: with a flavin as0
Recent patents
- Small molecules for dual function positron emission tomography (PET) and cell suicide switches4 Aug 2026US 12,697,403 B2The Trustees of the University of Pennsylvania
- Analyte sensors and sensing methods for detecting creatinine28 Jul 2026US 12,693,255 B2Abbott Diabetes Care Inc.
- Biosynthesis of eriodictyol30 Jun 2026US 12,668,804 B2Conagen Inc.
- Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,4-butanediol related thereto30 Jun 2026US 12,668,820 B2Genomatica, Inc.
- Detection of environmental influences by bioluminescence2 Jun 2026US 12,644,104 B2Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen
- Analyte sensors and sensing methods for detecting creatinine8 Oct 2026US 2026/0309669 A1Abbott Diabetes Care Inc.
- Analytical device for real time luminescence during temperature hold and ramp as used in real time cellular thermal shift assay1 Oct 2026US 2026/0297593 A1The United States of America, as represented by the Secretary, Department of Health and Human Serv
- Inducible programmed cell death-1 (pd1)-cytokine chimera for potentiated immune cell function24 Sep 2026US 2026/0284108 A1Seattle Children's Hospital d/b/a Seattle Children's Research Institute
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Production cell lines with targeted integration sites17 Sep 2026US 2026/0275373 A1Seagen Inc.
Most cited
By later US patents
- Methods of generating desired amino-terminal residues in proteins51US 5,093,242 AMassachusetts Institute of Technology · 1992
- Treatment using herpes simplex virus34US 7,897,146 B2Crusade Laboratories Limited · 2011
- Combination therapy with an anti-hyaluronan agent and therapeutic agent23US 9,913,822 B2Halozyme, Inc. · 2018
- Protein enriched microvesicles and methods of making and using the same19US 9,593,356 B2Takara Bio USA, Inc. · 2017
- Engineered imine reductases and methods for the reductive animation of ketone and amine compounds16US 9,193,957 B2Codexis, Inc. · 2015